Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNo significant changes to the study details or eligibility information are evident; the content appears unchanged aside from minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange Detected- Added a government funding notice and operating-status details; updated operating info link references. - Version updated from v3.0.2 to v3.2.0.SummaryDifference1%

- Check38 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page has had high-importance terms in drug safety and quality removed, narrowing the scope of content related to drug safety and quality concerns.SummaryDifference0.1%

- Check52 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 is shown; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page has updated the citation for a study on Alzheimer's disease, reflecting a new version and a change in publication date.SummaryDifference0.3%

Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.